Ocular discomfort by environmental and personal risk factors altering the precorneal tear film

Toxicology Letters

Volumn 199, Issue 3, 2010, Pages 203-212

  Wolkoff, Peder ^a  

^a NATIONAL RESEARCH CENTRE FOR THE WORKING ENVIRONMENT   (Denmark)

Author keywords

Air pollutants; Chemesthesis; Ocular discomfort; Ozone; Precorneal tear film; VOCs

Indexed keywords

1 OCTEN 3 OL; 2 BUTOXYETHANOL; 2 OCTANON; 2 PENTANONE; 2,3 BUTANEDIONE; 3 CARENE; 3 OCTANOL; 3 OCTANON; ACETALDEHYDE; ACETIC ACID; ACROLEIN; AMMONIA; BUTANOL; CAPROLACTAM; DECANE; ESSENTIAL FATTY ACID; FORMALDEHYDE; FORMIC ACID; GLUTARALDEHYDE; HEXANAL; HYDROGEN PEROXIDE; LIMONENE; METHACROLEIN; N METHYL 2 PYRROLIDON; NITROGEN CHLORIDE; PENTANAL; PERACETIC ACID; PINENE; TOLUENE; UNCLASSIFIED DRUG; VOLATILE ORGANIC COMPOUND;

AEROSOL; AIR POLLUTANT; AIRBORNE PARTICLE; AMBIENT AIR; CHEMESTHESIS; CLIMATE; COMBUSTION; COMPUTER; DIAGNOSTIC TEST; ENVIRONMENTAL FACTOR; ENVIRONMENTAL TEMPERATURE; EVAPORATION; EYE DISCOMFORT; EYE IRRITATION; GAZE; HUMAN; HUMIDITY; INDOOR AIR POLLUTION; OCCUPATIONAL HAZARD; ODOR; PRIORITY JOURNAL; REVIEW; RISK FACTOR; SKIN SENSITIVITY; TEAR FILM; TRIGEMINAL NERVE;

AIR POLLUTANTS; AIR POLLUTION, INDOOR; CLIMATE; DRY EYE SYNDROMES; EYE DISEASES; FATTY ACIDS, ESSENTIAL; HUMANS; IRRITANTS; OCCUPATIONAL DISEASES; RISK FACTORS; TEARS;

EID: 78650515725     PISSN: 03784274     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxlet.2010.09.001     Document Type: Review

References (191)

1. Abelson M.B., Ousler G.W., Nally L.A., Welch D., Krenzer K. Alternative reference values for tear film break up time in normal and dry eye populations. Lacrimal Gland, Tear Film, and Dry Eye Syndrome 2002, vol. 3:1121-1125. Kluwer Academic/Plenum Publishers, New York.
2. Alarie Y. Dose-response analysis in animal studies: prediction of human responses. Environ. Health Perspect. 1981, 42:9-13.
3. Alarie Y., Schaper M., Nielsen G.D., Abraham M.H. Estimating the sensory irritating potency of airborne nonreactive volatile organic chemicals and their mixtures. SAR/QSAR Environ. Res. 1996, 5:151-165.
4. Apte M.G., Buchanan I.S.H., Mendell M.J. Outdoor ozone and building-related symptoms in the BASE study. Indoor Air 2008, 18:156-170.
5. Arita R., Itoh K., Inoue K., Amano S. Noncontact infrared meibomography to document age-related changes of the meibomian glands in a normal population. Ophthalmology 2008, 115:911-915.
6. Aydemir, E., Breward, C.J., Witelski, T.P., in press. The effect of polar lipids on tear film dynamics. Bull. Math. Biol.
7. Ayer H.E., Yeager D.W. Irritants in cigarette smoke plumes. Am. J. Public Health 1982, 72:1283-1285.
8. Bælum J., Lundquist G.R., Mølhave L., et al. Human response to varying concentrations of toluene. Int. Arch. Occup. Environ. Health 1990, 62:65-71.
9. Ballantyne B., Snellings W.M., Norris J.C. Respiratory peripheral chemosensory irritation, acute and repeated exposure toxicity studies with aerosols of triethylene glycol. J. Appl. Toxicol. 2006, 26:387-396.
10. Baradino S., Shen L., Chen L., et al. The controlled-environment chamber: a new mouse model of dry eye. Invest. Ophthalmol. Vis. Sci. 2005, 46:2766-2771.
11. Basu P.K., Pimm P.E., Shephard R.J., et al. The effect of cigarette smoke on the human tear film. Can. J. Opthalmol. 1978, 13:22-26.
12. Benelli U., Nardi M., Posarelli C., et al. Tear osmolarity measurement using the TearLab Osmolarity System in the assessment of dry eye treatment effectiveness. Cont. Lens Ant. Eye 2010, 33:61-67.
13. Bitton E., Lovasik J.V. Longitudinal analysis of precorneal tear film rupture patterns. Adv. Exp. Med. Biol. 1998, 438:381-389.
14. Blackie, C.A., Solomon, J.D., Scaffidi, R.C., et al., 2010. The relationship between dry eye symptoms and lipid layer thickness. Cornea 28, 789-794.
15. Bluyssen P.M., et al. European Indoor Air Quality Audit Project in 56 Office Buildings. Indoor Air 1996, 6:221-238.
16. Bonvallot N., Giorennec P., Zmirou D. Derivation of a toxicity reference value for nitrogen trichloride-a disinfection by-product. Regul. Toxicol. Pharmacol. 2010, 56:357-364.
17. Borchman D., Foulks G.N., Yappert M.C., et al. Physical changes in human meibum with age as measured with infrared spectroscopy. Ophthal. Res. 2010, 17:34-42.
18. Borchman D., Foulks G.N., Yappert M.C., et al. Factors affecting evaporation rates of tear film components measured in vitro. Eye Cont. Lens 2009, 35:32-37.
19. Bourcier T., Viboud C., Cohen J.-C., et al. Effects of air pollution and climatic conditions on the frequency of ophthalmological emergency examinations. Br. J. Ophthalmol. 2003, 87:809-811.
20. Brightman H.S., Milton D.K., Wypij D., et al. Evaluating building-related symptoms using the US EPA BASE study results. Indoor Air 2008, 18:335-345.
21. Bron A.J., Tiffany J.M. The contribution of meibomian disease to dry eye. Ocul. Surf. 2004, 2:149-164.
22. Bron A.J., Yokoi N., Gafney E., et al. Predicted phenotypes of dry eye: proposed consequences of its natural history. Ocul. Surf. 2009, 7:78-92.
23. Brown S.I. Dry spots and corneal erosions. Int. Ophthalmol. Clin. 1973, 13:149-156.
24. Bruce A.S., Mainstone J.C., Golding T.R. Analysis of tear film breakup on Etafilcon A hydrogel lenses. Biomaterials 2001, 22:3249-3256.
25. Butovich I.A. The Meibomian puzzle: combining pieces together. Prog. Retin. Eye Res. 2009, 28:483-498.
26. Butovich I.A., Wojtowicz J., Molai M. Human tear film and meibum. Very long chain wax esters and O-acyl-omegahydroxy fatty acids of meibum. J. Lipid Res. 2009, 50:2471-2485.
27. Cain W.S., de Wijk R.A., Jalowayski A.A., et al. Odor and chemesthesis from brief exposure to TXiB. Indoor Air 2005, 15:445-458.
28. Cain, W.S., Dourson, M.L., Kohrman-Vincent, M.J., et al., in press. Human chemosensory perception of methyl isothiocyanate: odor and chemesthesis. Regul. Pharm. Toxicol.
29. Cain W.S., Schmidt R. Can we trust odor databases? Example of t- and n-butyl acetate. Atmos. Environ. 2009, 43:2591-2601.
30. Cain W.S., Schmidt R., Jalowayski A.A. Odor and chemosthesis from exposure to glutaraldehyde vapor. Int. Arch. Occup. Environ. Health 2007, 80:721-731.
31. Calonge M., Enriquez-de-Salamanca A., Diebold Y., et al. Dry eye disease as an inflammatory disorder. Ocul. Immunol. Inflamm. 2010, 18:190-199.
32. Chen W., Zhang X., Zhang J., et al. Murine model of dry eye induced by an intelligently controlled environmental system. Invest. Ophthal. Vis. Sci. 2008, 49:1386-1391.
33. Chen Y., Metha G., Vasiliou V. Antioxidant defenses in the ocular surface. Ocul. Surf. 2010, 7:176-185.
34. Cho P., Brown B., Chan I., et al. Reliability of the tear break-up time technique of assessing tear stability and the locations of the tear break-up in Hong Kong Chinese. Optom. Vis. Sci. 1992, 69:879-885.
35. Collins M.J., Stahmer D., Pearson G. Clinical findings associated with incomplete blinking in soft lens wearers. Clin. Exp. Optom. 1989, 72:55-60.
36. Craig J.P. Structure and function of the preocular tear film. The Tear Film: Structure, Function and Clinical Examination 2002, Butterworth-Heinemann, Oxford, pp. 18-50.
37. Dalton P.H., Jaén C. Responses to odors in occupational environments. Curr. Opin. Allergy Clin. Immunol. 2010, 10:127-132.
38. Dang B., Chen L., Mueller C., et al. Ocular and respiratory symptoms among lifeguards at a indoor waterpark resort. J. Occup. Environ. Hyg. 2010, 52:207-213.
39. DeCeaurriz J.C., Micillino J.C., Bonnet P., et al. Sensory irritation caused by various industrial airborne chemicals. Toxicol. Lett. 1981, 9:137-143.
40. Doty R.L., Cometto-Muñiz J.E., Jalowayski A.A., et al. Assessment of upper respiratory tract and ocular irritative effects of volatile chemicals in humans. Crit. Rev. Toxicol. 2004, 34:85-142.
41. Doughty M. Diagnostic and therapeutic pharmaceutical agents for use in contact lens practice. Clin. Cont. Lens Prac./Basic Topics 1996, 1-38. Chapter 9.
42. Dourson, M.L., Kohrman-Vincent, M.J., Allen, B.C., in press. Dose response assessment for effects of acute exposure to methyl isothiocyanate. Regul. Toxicol. Pharmacol.
43. Dry Eye Workshop The definition and classification of dry eye disease: report of the definition and classification subcommittee of the International Dry Eye Workshop 2007. Ocul. Surf. 2007, 5:75-92.
44. Dry Eye Workshop Methodologies to diagnose and monitor dry eye disease: report of the diagnostic methodology subcommittee of the International Dry Eye Workshop 2007. Ocul. Surf. 2007, 5:108-123.
45. Emmen H.H., Muijser H., Arts J.H., et al. Human volunteer study with PGME: eye irritation during vapour exposure. Toxicol. Lett. 2003, 140-141:249-259.
46. Erdmann C.A., Apte M.G. Mucous membrane and lower respiratory building related symptoms in relation to indoor carbon dioxide concentrations in 100-building BASE dataset. Indoor Air 2004, 14:127-134.
47. Ernstgård L., Iregren A., Sjögren B., et al. Acute effects of exposure to vapors of acetic acid in humans. Toxicol. Lett. 2006, 165:22-30.
48. Ernstgård L., Iregren A., Sjögren B., et al. Acute effects of exposure to hexanal vapors in humans. J. Occup. Environ. Med. 2006, 48:573-580.
49. Ernstgård L., Löf A., Wieslander G., et al. Acute effects of some volatile organic compounds emitted from water-based paints. J. Occup. Environ. Med. 2007, 49:880-889.
50. 3 of vaporized 2-ethyl-1-hexanol in humans. Indoor Air 2010, 20:168-175.
51. Falk A., Löf A., Hagberg M., et al. Human exposure to 3-carene by inhalation: toxicokinetics, effects on pulmonary function and occurrence of irritative and CNS symptoms. Toxicol. Appl. Pharmacol. 1991, 110:198-205.
52. Falk A.A., Hagberg M.T., Löf A., et al. Uptake, distribution and elimination of -pinene in man after exposure by inhalation. Scand. J. Work Environ. Health 1990, 16:372-378.
53. Falk-Filipsson A., Löf A., Hagberg M., et al. d-Limonene exposure to humans by inhalation: uptake, distribution, elimination, and effects on the pulmonary function. J. Toxicol. Environ. Health 1993, 38:77-88.
54. Farris R.L. The diagnosis and management of the dry eye. J. Ophthal. Nurs. Technol. 1997, 16:164-174.
55. Fiedler N., Laumbach R., Kelly-McNeil K., et al. Health effects of a mixture of indoor air volatile organics, their ozone oxidation products, and stress. Environ. Health Perspect. 2005, 113:1542-1548.
56. Fostervold K.I., Aaras A., Lie I. Work with visual display units: long-term health effects and high and downward line-of-sight in ordinary office environments. Int. J. Ind. Ergon. 2006, 36:331-343.
57. Foulks G.N. The correlation between the tear film lipid layer and dry eye disease. Surv. Ophthalmol. 2007, 52:369-374.
58. Gagnaire F., Axim S., Bonnet P., et al. Comparison of the sensory irritation response in mice to chlorine and nitrogen trichloride. Regul. Toxicol. Pharmacol. 1994, 14:405-409.
59. Gagnaire F., Marignac B., Hecht G., et al. Sensory irritation of acetic acid, hydrogen peroxide, and peroxyacetic acid and their mixture in mice. Ann. Occup. Hyg. 2002, 46:97-102.
60. Gayton J.L. Etiology, prevalence, and treatment of dry eye disease. Clin. Ophtalmol. 2009, 3:405-412.
61. Gilbard J.P. Dry eye and blepharitis: approaching the patient with chronic eye irritation. Geriatrics 2009, 64:22-26.
62. Goto E., Monden Y., Takano Y., et al. Treatment of non-inflamed obstructive meibomian gland dysfunction by an infrared warm compression device. Br. J. Ophthal. 2002, 86:1403-1407.
63. Guillon J.-P. Current clinical techniques to study the tear film and tear secretions. The Tear Film: Structure, Function and Clinical Examination 2002, Butterworth-Heinemann, Oxford, pp. 51-81.
64. Guillon M., Maïssa C. Contact lens wear affects tear film evaporation. Eye Cont. Lens 2008, 36:326-330.
65. Guo B., Lu P., Chen X., et al. Prevalence of dry eye disease in Mongolians at high altitude in China: the Henan eye study. Opthal. Epidemiol. 2010, 17:234-241.
66. Hansen L.F., Nielsen G.D. Sensory irritation and pulmonary irritation of n-methyl ketones: receptor activation mechanisms and relationships with threshold limit values. Arch. Toxicol. 1994, 68:193-202.
67. Hau K.M., Connell D.W., Richardson B.J. Use of partition models in setting health guidelines for volatile organic compounds. Regul. Toxicol. Pharmacol. 2000, 31:22-29.
68. Hedge A., Erickson A., Rubin G. Predicting sick building syndrome at the individual and aggregate levels. Environ. Int. 1996, 22:3-19.
69. Hempel-Jørgensen A., Kjærgaard S.K., Mølhave L., et al. Time course of sensory eye irritation in humans exposed to n-butanol and 1-octene. Arch. Environ. Health 1999, 54:86-94.
70. Henning R.A., Jacques P., Kissel G.V., et al. Frequent short rest breaks from computer work: effects on productivity and well-being at two field sites. Ergonomics 1997, 40:78-91.
71. Himebaugh N., Begley C.G., Bradley A., et al. Blinking and tear break-up during four visual tasks. Optom. Vis. Sci. 2009, 86:E106-E114.
72. Hummel T., Futschik T., Frasnelli J., et al. Effects of olfactory function, age, gender on trigeminally mediated sensations: a study base on the lateralization of chemosensory stimuli. Toxicol. Lett. 2003, 140-141:273-280.
73. Iregren A., Löf A., Toomingas A., et al. Irritation effects from experimental exposure to n-butyl acetate. Am. J. Ind. Med. 1993, 24:727-742.
74. Jansen M.E., Begley C.G., Himebaugh N.H., et al. Effect of contact lens wear and a near task on tear film break-up. Optom. Vis. Sci. 2010, 87:350-357.
75. Joffre C., Souchier M., Grégoire S., et al. Differences in meibomian fatty acid composition in patients with meibomian gland dysfunction and aqueous-deficient dry eye. Br. J. Ophthal. 2008, 92:116-119.
76. Johnson M.E. The association between symptoms of discomfort and signs in dry eye. Ocul. Surf. 2010, 7:199-211.
77. Kaczmarczyk J., Melikov A., Sliva D. Effect of warm air supplied facially on occupants' comfort. Build. Environ. 2010, 45:848-855.
78. Kane L.E., Dombroske B.S., Alarie Y. Evaluation of sensory irritation from some common industrial solvents. Am. Ind. Hyg. Assoc. J. 1980, 41:451-455.
79. Kasanen J.-P., Pasanen A.-L., Pasanen P., et al. Evaluation of sensory irritation of 3-carene and turpentine, and acceptable levels of monoterpenes in occupational and indoor environment. J. Toxicol. Environ. Health, Part A 1999, 56:89-114.
80. Khanal S., Tomlinson A., McFadyen A., et al. Dry eye diagnosis. Invest. Ophthalmol. Vis. Sci. 2008, 49:1407-1414.
81. Kiesswetter E., van Thriel C., Schaper M., et al. Eye blinks as indicator for sensory irritation during constant and peak exposures to 2-ethylhexanol. Environ. Toxicol. Pharmacol. 2005, 19:531-541.
82. Kimball, S.H., King-Smith, P.E., Nichols, J.J., in press. Evaporation of the primary mechanism of tear film thinning between blinks. Invest. Ophthal. Vis. Sci.
83. 2 with a monolayer of oleic acid at the air-water interface-a simple proxy for atmospheric aerosol. Atmos. Environ. 2010, 44:1822-1825.
84. King-Smith P.E., Fink B.A., Nichols J.J., et al. The contribution of lipid layer movement to tear film thinning and breakup. Invest. Ophthal. Vis. Sci. 2009, 50:2747-2756.
85. King-Smith P.E., Hinel E.A., Nichols J.J. Application of a novel interferometric method to investigate relation between lipid layer thickness and tear film thinning. Invest. Ophthal. Vis. Sci. 2010, 51:2418-2423.
86. King-Smith P.E., Nichols J.J., Nichols K.K., et al. Contribution of evaporation and other mechanisms to tear film thinning and break-up. Optom. Vis. Sci. 2008, 85:623-630.
87. Kinoshita S., Kiorpes T.C., Friend J., et al. Goblet cell density in ocular surface disease: a better indicator than tear mucin. Arch. Ophthalmol. 1983, 101:1284-1287.
88. Kjærgaard S.K., Hempel-Jørgensen A., Mølhave L., et al. Eye trigeminal sensitivity, tear film stability, and conjunctival epithelium damage in 182 non-allergic, non-smoking Danes. Indoor Air 2004, 14:200-207.
89. Kjærgaard S.K., Mølhave L., Pedersen O.F. Human reactions to indoor air pollutants: n-decane. Environ. Int. 1989, 15:473-482.
90. Kjærgaard S.K., Pedersen O.F., Mølhave L. Sensitivity of the eyes to airborne irritant stimuli: Influence of individual characteristics. Arch. Environ. Health 1992, 47:45-50.
91. Knop E., Korb D.R., Blackie C.A., et al. The lid margin is an underestimated structure for preservation of ocular surface health and development of eye disease. Dev. Ophthalmol. 2010, 45:108-122.
92. Korb D.R. The tear film-its role today and in the future. The Tear Film-Structure, Function and Clinical Examination 2002, Butterworth Heinemann, Oxford, pp. 126-192.
93. Korb D.R., Blackie C.A. Meibomian gland diagnostic expressibility: correlation with dry eye symptoms and gland location. Cornea 2008, 27:1142-1147.
94. Korb D.R., Blackie C.A. Restoration of meibomian gland functionality with novel thermodynamic treatment device-a case story. Cornea 2010, 29:930-933.
95. Korpi A., Kasanen J.-P., Alarie Y., et al. Sensory irritating potency of some microbial volatile organic compounds MVOCs and a mixture of five MVOCs. Arch. Environ. Health 1999, 54:347-352.
96. Korzak Z., Rydzynski K. Effects of acute combined inhalation exposure to n-butyl alcohol and butyl acetate in experimental animals. Int. J. Occup. Med. Environ. Health 1994, 7:273-280.
97. Korzak Z., Swiercz R., Jedrychowski R. Effects of acute combined exposure to n-butyl alcohol and m-xylene. Pol. J. Occup. Med. Environ. Health 1993, 6:35-41.
98. Kristiansen U., Nielsen G.D. Activation of the sensory irritant receptor by C7-C11 n-alkanes. Arch. Toxicol. 1988, 61:419-425.
99. Kuizenga A., van Haeringen N.J., Kijlstra A. Inhibition of hydroxyl radical formation by human tears. Invest. Ophthalmol. Vis. Sci. 1987, 28:305-313.
100. Kulle T.J. Acute odor and irritation response in healthy nonsmokers with formaldehyde exposure. Toxicol. Ind. Health 1993, 5:323-332.
101. Kuwabara Y., Alexeeff G.V., Broadwin R., et al. Evaluation and application of the RD50 for determining acceptable exposure levels of airborne sensory irritants for the general public. Environ. Health Perspect. 2007, 115:1609-1616.
102. Lang I., Bruckner T., Triebig G. Formaldehyde and chemosensory irritation in humans: a controlled human exposure study. Regul. Toxicol. Pharmacol. 2008, 50:23-36.
103. Larsen S.T., Alarie Y., Hammer M., et al. Acute airway effects of diacetyl in mice. Inhal. Toxicol. 2009, 21:1123-1128.
104. Larsen S.T., Hougaard K.S., Alarie Y., et al. Effects of R-+- and S--- limonene on the respiratory tract in mice. Hum. Exp. Toxicol. 2000, 19:457-466.
105. Larsen S.T., Nielsen G.D. The effects of methacrolein on the respiratory tract in mice. Toxicol. Lett. 2000, 114:197-202.
106. Leonardi A., Lanier B. Urban eye allergy syndrome: a new clinical entity. Curr. Med. Res. Opin. 2008, 24:2295-2302.
107. Maïssa C., Guillon M. Tear film dynamics and lipid layer characteristics-effect of age and gender. Cont. Lens Ant. Eye 2010, 33:171-175.
108. Maïssa C., Guillon M., Simmons P., et al. Effect of castor oil emulsion eyedrops on tear film composition and stability. Cont. Lens Ant. Eye 2010, 33:76-82.
109. McCarty C.A., Bansal A.K., Livingston P.M., et al. The epidemiology of dry eye in Melbourne, Australia. Ophthalmology 1998, 105:1114-1119.
110. McDonald J.D., Eisele M., Campen M.J., et al. Cardiopulmonary response to inhalation of biogenic secondary organic aerosol. Inhal. Toxicol. 2010, 22:253-265.
111. McDonald J.E., Brubaker S. Miniscus-induces thinning of tear films. Am. J. Ophthalmol. 1971, 72:139-146.
112. Messmer E.M., Bulgen M., Kampik A. Hyperosmolarity of the tear film in dry eye syndrome. Dev. Ophthalmol. 2010, 45:129-138.
113. Mølhave L. Inflammatory and allergic responses to airborne dust office in five human provocation experiments. Indoor Air 2008, 18:261-270.
114. Montés-Micó R. Role of the tear film in the optical quality of the human eye. J. Cataract Refract. Surg. 2007, 33:1631-1635.
115. Morris J.B., Symanowicz P.T., Olsen J.E., et al. Immediate sensory nerve-mediated respiratory responses to irritants in healthy and allergic airway-diseased mice. J. Appl. Physiol. 2003, 94:1563-1571.
116. Moss S.E., Klein R., Klein B.E. Long-term incidence of dry eye in an older population. Optom. Vis. Sci. 2008, 85:668-674.
117. Muller J., Greff G. Recherche de relations entre toxicité de molecules d'interet industriel et proprietes physico-chimiques test d'irritation des voies aeriennes superieures appliques à quatre familles chimiques. Food Chem. Toxicol. 1984, 22:661-664.
118. Nagyová B., Tiffany J.M. Components responsible for the surface tension of human tears. Curr. Eye Res. 1999, 19:4-11.
119. Nakamura S., Kinoshita S., Yokoi N., et al. Lacrimal hypofunction as a new mechanism of dry eye in visual display terminal users. PLos ONE 2010, 5:e11119.
120. Nelson J.D., Wright J.C. Conjunctival goblet cell densities in ocular surface disease. Arch. Ophthalmol. 1984, 102:1049-1051.
121. Nichols K.K., Nichols J.J., Mitchell G.L. The lack of association between signs and symptoms in patients with dry eye disease. Cornea 2004, 23:762-770.
122. Nielsen G.D., Hansen L.F., Hammer M. Eye and Airway Irritation Effects of Organic Acids 1996, Working Environment Fund, Copenhagen, pp. 1-50.
123. Nielsen G.D., Hansen L.F., Wolkoff P. Chemical and biological evaluation of building material emissions. II. Approaches for setting indoor air standards or guidelines for chemicals. Indoor Air 1997, 7:17-32.
124. Nielsen G.D., Hougaard K.S., Larsen S.T., et al. Acute airway effects of formaldehyde and ozone in BALB/c mice. Hum. Exp. Toxicol. 1999, 18:400-409.
125. Nielsen G.D., Larsen S.T., Hougaard K.S., et al. Mechanisms of acute inhalation effects of + and -α-pinene in BALB/c mice. Pharmacol. Toxicol. 2005, 96:1-9.
126. Nielsen G.D., Wolkoff P., Alarie Y. Sensory irritation: risk assessment approaches. Regul. Toxicol. Pharmacol. 2007, 48:6-18.
127. Nielsen G.D., Larsen S.T., Olsen O., et al. Do indoor chemicals promote development of airway allergy?. Indoor Air 2007, 17:236-255.
128. Nielsen P.K., Søgaard K., Skotte J., et al. Ocular surface area and human eye blink frequency during VDU work-the effect of monitor position and task. Eur. J. Appl. Physiol. 2008, 103:1-7.
129. Norn M.S. External Eye. Methods of Examination 1983, Scriptor, Copenhagen.
130. Novaes P., do Nascimento Saldiva P.H., Matsuda M., et al. The effects of chronic exposure to traffic derived air pollution on the ocular surface. Environ. Health 2010, 110:372-374.
131. O'Brien P.D., Collum L.M.T. Dry eye: diagnosis and current treatment strategies. Curr. Allergy Asthma Rep. 2004, 4:314-319.
132. Ohashi Y., Dogru M., Tsubota K. Laboratory findings in tear fluid analysis. Clin. Chim. Acta 2006, 369:17-28.
133. Ozdemir M., Temizdemir H. Age- and gender-related tear function changes in normal population. Eye 2010, 24:79-83.
134. Palomäki E., Uitti J., Virtema P., et al. Decreasing irritation symptoms by replacing partially coated acoustic glass wool boards with fully coated boards. Scand. J. Work Environ. Health Suppl. 2008, 2008:64-68.
135. Pasanen A.-L., Korpi A., Kasanen J.-P., Pasanen P. Critical aspects on the significance of microbial volatile metabolites as indoor air pollutants. Environ. Int. 1998, 24:703-712.
136. Piccoli B. A critical appraisal of current knowledge and future directions of ergophthalmology. Ergonomics 2003, 46:384-406.
137. Rashid S., Jin Y., Ecoiffer T., et al. Topical omega-3 and omega-6 fatty acids for treatment of dry eye. Arch. Ophthalmol. 2008, 126:219-225.
138. Rengstorff R.H. The precorneal tear film: breakup time and location in normal subjects. Am. J. Optom. Physiol. Opt. 1974, 51:765-769.
139. Roncone M., Barlett H., Eperjesi F. Essential fatty acids for dry eye: a review. Cont. Lens Ant. Eye 2010, 33:49-54.
140. Rose R.C., Richer S.P., Bode A.M. Ocular oxidants and antioxidant protection. Proc. Soc. Exp. Biol. Med. 1998, 217:397-407.
141. Rosenberg E.S., Asbell P.A. Essential fatty acids in the treatment of dry eye. Ocul. Surf. 2010, 8:18-28.
142. Rummenie V.T., Matsumoto Y., Dogru M., et al. Tear cytokine and ocular surface alterations following brief passive cigarette smoke exposure. Cytokine 2008, 43:200-208.
143. Runeson R., Norbäck D., Stattin H. Symptoms and sense of coherence SOC-a follow-up study of personnel from workplace buildings with indoor air problems. Int. Arch. Occup. Environ. Health 2003, 76:29-38.
144. Saha A., Kulkarni P.K., Shah A., et al. Ocular morbidity and fuel use: an experience from India. Occup. Environ. Med. 2005, 62:66-69.
145. Salonen H., Pasanen A.-L., Lappalainen S., et al. Volatile organic compounds and formaldehyde as explaining factors for sensory irritation in office environments. J. Occup. Environ. Hyg. 2009, 6:239-247.
146. Salthammer T., Mentese S., Marutzky R. Formaldehyde in the indoor environment. Chem. Rev. 2010, 110:2536-2572.
147. Satici A., Bitiren M., Ozardali I., et al. The effects of chronic smoking on the ocular surface and tear characteristics: a clinical, histological and biochemical study. Acta Ophthalmol. Scand. 2003, 81:583-587.
148. Saxena R., Srivastava S., Trivedi D., et al. Impact of environmental pollution on the eye. Acta Ophthalmol. Scand. 2003, 81:491-494.
149. Sheedy J.E., Hayes J.N., Engle J. Is all asthnopia the same?. Optom. Vis. Sci. 2003, 80:732-739.
150. Shine W.E., McCulley J.P. Association of meibum oleic acid with meibomian seborrhea. Cornea 2000, 19:72-74.
151. Smeets M.A.M., Bulsing P.J., van Rooden S., et al. Odor and irritation thresholds for ammonia: a comparison between static and dynamic olfactometry. Chem. Sens. 2007, 32:11-20.
152. Smith J.A., Albietz J., Begley C., et al. The epidemiology of dry eye disease: report of the epidemiology Subcommittee of the international dry eye workshop 2007. Ocul. Surf. 2007, 5:93-107.
153. Squadrito G.L., Cueto R., Dellinger B., et al. Quinoid redox cycling as a mechanism for sustained free radical generation by inhaled airborne particulate matter. Free Radic. Biol. Med. 2001, 31:1132-1138.
154. Stahl U., Willcox M., Stapleton F. Role of hypo-osmotic saline drops in ocular comfort during contact lens wear. Cont. Lens Ant. Eye 2010, 33:68-75.
155. Stahl U., Willcox M.D., Naduvilath T., et al. Influence of tear film and contact lens osmolarity on ocular comfort in contact lens wear. Optom. Vis. Sci. 2009, 86:857-867.
156. Steinhagen W.H., Barrow C.S. Sensory irritation structure-activity study of inhaled aldehydes in B6C3F1 and Swiss-Webster mice. Toxicol. Appl. Pharmacol. 1984, 72:495-503.
157. Stephens E.R., Darley E.F., Taylor O.C., et al. Photochemical reaction products in air pollution. Int. J. Air Water Pollut. 1961, 4:79-100.
158. Sullivan D.A. Tearful relationships? Sex, hormones, the lacrimal gland, and aqueous-deficient dry eye. Ocul. Surf. 2004, 2:92-123.
159. Suzuki M., Massingale M., Ye F., Godbold J., et al. Tear osmolarity as a biomarker for dry eye disease severity. Invest. Ophthalmol. Vis. Sci. 2010, 51:4557-4561.
160. Troiano P., Monaco G. Effect of hypotonic 0.4% hyaluronic acid drops in dry patients: a cross-over study. Cornea 2008, 27:1126-1130.
161. Tsubota K., Hata S., Okusawa Y., Egami F., Ohtsuki T., Nakamori K. Quantitative videographic analysis of blinking in normal subjects and patients with dry eye. Arch. Ophthalmol. 1996, 114:715-720.
162. Uchino M., Schaumberg D.A., Dogru M., et al. Prevalence of dry eye disease among Japanese visual display terminal users. Ophthalmology 2008, 115:1982-1988.
163. van Thriel C., Blaszkewicz M., Schäper M., et al. Chemosensory effects during acute exposure to N-methyl-2-pyrrolidon NMP. Toxicol. Lett. 2007, 175:44-56.
164. van Thriel C., Kiesswetter E., Schaper M., et al. An integrated approach considering acute symptoms and intensity ratings of chemosensory sensations during experimental exposures. Environ. Toxicol. Pharmacol. 2005, 19:589-598.
165. van Thriel C., Schäper M., Kiesswetter E., et al. From chemosensory thresholds to whole body exposures-experimental approaches evaluating effects of chemicals. Int. Arch. Occup. Environ. Health. 2006, 79:308-321.
166. van Thriel C., Seeber A., Kiesswetter E., et al. Physiological and psychological approaches to chemosensory effects of solvents. Toxicol. Lett. 2003, 140-141:261-271.
167. Varikooty J., Simpson T.L. The interblink interval. I. The relationship between sensation intensity and tear film disruption. Invest. Ophthalmol. Vis. Sci. 2009, 50:1087-1092.
168. Varma S.D., Ali A.H., Devamanoharan P.S., et al. Nitrite-induced photo-oxidation of thiol and its implication in smog toxicity to the eye: prevention by ascorbate. J. Ocul. Pharmacol. Ther. 1997, 13:179-187.
169. Versura P., Profazio V., Cellini M., et al. Eye discomfort and air pollution. Ophthalmologica 1999, 213:103-109.
170. Viso E., Rodriguez-Ares M., Gude F. Prevalence of and associated factors for dry eye in a Spanish adult population. The Salnes Eye Study. Opthal. Epidemiol. 2009, 16:15-21.
171. Vyskocil A., Viau C., Lamy S. Peroxyacetyl nitrate: review of toxicity. Hum. Exp. Toxicol. 1998, 17:212-220.
172. Ward S.K., Dogru M., Wakamatsu T., et al. Passive cigarette smoke exposure and soft contact lens wear. Optom. Vis. Sci. 2010, 87:372-376.
173. Werley M.S., Burleigh-Flayer H.D., Ballantyne B. Respiratory peripheral sensory irritation and hypersensitivity studies with glutaraldehyde vapor. Toxicol. Ind. Health 1995, 11:489-501.
174. Weschler C.J. Ozone in indoor environments: concentrations and chemistry. Indoor Air 2000, 10:269-288.
175. Wheeler A.J., Smith-Doiron M., Xu X., et al. Intra-urban variability of air pollution in Windsor, Ontario-measurement and modeling for human exposure assessment. Environ. Res. 2008, 106:7-16.
176. Wieslander, G., Norbäck, D., 2010a. Ocular symptoms, tear film stability, nasal patency, and biomarkers in nasal lavage in indoor painters in relation to emissions from water-based paint. Int. Arch. Occup. Environ. Health.
177. Wieslander G., Norbäck D. A field study on clinical signs and symptoms in cleaners at polish removal and application in a Swedish hospital. Int. Arch. Occup. Environ. Health 2010, 83:585-591.
178. Wise P.M., Zhao K., Wysocki C.J. Dynamics of nasal chemesthesis. Ann. N.Y. Acad. Sci. 2009, 1170:206-214.
179. Wojtowicz J.C., Butovich I.A., McCulley J.P. Historical brief on composition of human meibum lipids. Ocul. Surf. 2009, 7:145-153.
180. Wolkoff P. Healthy eye in office-like environments. Environ. Int. 2008, 34:1204-1214.
181. Wolkoff P., Clausen P.A., Larsen K., et al. Acute airway effects of ozone-initiated d-limonene chemistry: importance of gaseous products. Toxicol. Lett. 2008, 181:171-176.
182. Wolkoff P., Nielsen G.D. Non-cancer effects of formaldehyde and relevance for setting an indoor air guideline. Environ. Int. 2010, 36:788-799.
183. Wolkoff P., Skov P., Franck C., et al. Eye irritation and environmental factors in the office environment. Hypotheses, causes, and a physiological model. Scand. J. Work Environ. Health 2003, 29:411-430.
184. Wong H., Fatt I., Radke C.J. Deposition and thinning of the human tear film. J. Colloid Interface Sci. 1996, 184:44-51.
185. Woodfield M., Hall D. Odour Measurement and Control-An Update 1994, AEA Technology, Culham, Abingdon, pp. 1-19.
186. World Health Organization Dampness and Mould. WHO Guidelines for Indoor Air Quality 2009, WHO Regional Office for Europe, Copenhagen, pp. 1-227.
187. Yoon K.-C., Song B.-Y., Seo M.-S. Effects of smoking on tear film and ocular surface. Kor. J. Ophthal. 2005, 19:18-22.
188. Zhao J., Wollmer P. Air pollutants and tear film stability-a method for experimental evaluation. Clin. Physiol. 2001, 21:282-286.
189. Ziegler A., Zimmer H., Triebig G. Exposure study on chemosensory effects of δ-caprolactam in the low concentration range. Int. Arch. Occup. Environ. Health 2008, 81:743-753.
190. Zissu D., Gagnaire F., Bonnet P. Nasal and pulmonary toxicity of glutaraldehyde in mice. Toxicol. Lett. 1994, 71:53-62.
191. Wyon N.M., Wyon D.P. Measurement of acute response to draught in the eye. Acta Ophthalmol. 1987, 65:385-392.